sur Medicure, Inc. (NASDAQ:MCUJF)
Medicure to Announce Q2 2025 Financial Results via Conference Call
Medicure Inc., a company focused on pharmaceuticals and healthcare products in the U.S. market, is set to present its financial results for the quarter ended June 30, 2025. The announcement will occur during a conference call on August 21, 2025, at 8:30 am ET. The financial documents will be filed after the market closes on August 20, 2025.
The conference call will offer insights into Medicure's operations, including the marketing of AGGRASTAT® and ZYPITAMAG®. Medicure's pharmacy subsidiaries include Marley Drug and Gateway Medical Pharmacy, serving various U.S. states.
Participants can join the call through a toll-free line or via webcast, with a recording available post-call. Management will address financial and operational queries during the event.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Medicure, Inc.